NEOPROBE CORP
S-3/A, EX-23.1, 2000-06-12
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: NEOPROBE CORP, S-3/A, EX-5.1, 2000-06-12
Next: NEOPROBE CORP, S-3/A, EX-23.2, 2000-06-12



<PAGE>   1
                                                                    Exhibit 23.1


                       CONSENT OF INDEPENDENT ACCOUNTANTS

The Board of Directors
Neoprobe Corporation:

We consent to the use of our report dated February 14, 2000 incorporated herein
by reference.


                                                          /s/ KPMG LLP

Columbus, Ohio
June 12, 2000


                                      II-6


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission